3 ms·
Favipiravir is far less promising than ivermectin with ~100% cure rate if treated early. It is peer-reviewed now (ivermectin ICON study, single dose late stage
by pezo1919 6y ago
Favipiravir is far less promising than ivermectin with ~100% cure rate if treated early. It is peer-reviewed now (ivermectin ICON study, single dose late stage 40% mortality reduction.) I don't get why people on HN are not aware of it.
- hef19898 6y agoBecause HN is nit primarily populated by medical experts specialized in Virology? Just a guess.